» Articles » PMID: 38994522

Antibiotics and BCG

Overview
Journal Bladder Cancer
Publisher IOS Press
Date 2024 Jul 12
PMID 38994522
Authors
Affiliations
Soon will be listed here.
References
1.
Alexandroff A, Jackson A, ODonnell M, JAMES K . BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999; 353(9165):1689-94. DOI: 10.1016/S0140-6736(98)07422-4. View

2.
Redelman-Sidi G, Glickman M, Bochner B . The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nat Rev Urol. 2014; 11(3):153-62. DOI: 10.1038/nrurol.2014.15. View

3.
Dethlefsen L, Relman D . Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4554-61. PMC: 3063582. DOI: 10.1073/pnas.1000087107. View

4.
Wolfe A, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M . Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012; 50(4):1376-83. PMC: 3318548. DOI: 10.1128/JCM.05852-11. View

5.
Kamat A, Flaig T, Grossman H, Konety B, Lamm D, ODonnell M . Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer. Nat Rev Urol. 2015; 12(4):225-35. DOI: 10.1038/nrurol.2015.58. View